LV14230A - Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai - Google Patents
Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanaiInfo
- Publication number
- LV14230A LV14230A LVP-09-86A LV090086A LV14230A LV 14230 A LV14230 A LV 14230A LV 090086 A LV090086 A LV 090086A LV 14230 A LV14230 A LV 14230A
- Authority
- LV
- Latvia
- Prior art keywords
- parkinson
- disease
- prevention
- treatment
- pharmaceutical composition
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000018737 Parkinson disease Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- JFWLFLLRLZSBRA-UHFFFAOYSA-N 3-[(trimethylazaniumyl)amino]propanoate;dihydrate Chemical compound O.O.C[N+](C)(C)NCCC([O-])=O JFWLFLLRLZSBRA-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical compound C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 abstract 1
- 229960002937 meldonium Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Meldonija [3-(2,2,2-trimetilhidrazīnij)propionāta dihidrāta] un tā farmaceitiskai lietošanai atļauto sāļu lietošana Parkinsona slimības profilaksei un ārstēšanai.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-09-86A LV14230B (lv) | 2009-04-30 | 2009-04-30 | Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai |
PCT/EP2010/002658 WO2010124873A1 (en) | 2009-04-30 | 2010-04-30 | 3- (2, 2, 2, trimethylhydrazunium) propionate dihydrate (meldomium) for treating parkinson' s disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-09-86A LV14230B (lv) | 2009-04-30 | 2009-04-30 | Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai |
Publications (2)
Publication Number | Publication Date |
---|---|
LV14230A true LV14230A (lv) | 2010-11-20 |
LV14230B LV14230B (lv) | 2011-05-20 |
Family
ID=42651244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-09-86A LV14230B (lv) | 2009-04-30 | 2009-04-30 | Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai |
Country Status (2)
Country | Link |
---|---|
LV (1) | LV14230B (lv) |
WO (1) | WO2010124873A1 (lv) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2302011T3 (es) * | 2003-08-04 | 2008-07-01 | "JOINT STOCK COMPANY GRINDEKS" | Sales de meldonio, metodo para su preparacion y composicion farmaceutica basado en las mismas. |
-
2009
- 2009-04-30 LV LVP-09-86A patent/LV14230B/lv unknown
-
2010
- 2010-04-30 WO PCT/EP2010/002658 patent/WO2010124873A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
LV14230B (lv) | 2011-05-20 |
WO2010124873A8 (en) | 2011-03-31 |
WO2010124873A1 (en) | 2010-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
MX2020008616A (es) | Rocio de fentanilo sublingual. | |
SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
MX354210B (es) | Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas. | |
IL223783B (en) | Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine | |
WO2008149382A8 (en) | Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application | |
WO2009017837A3 (en) | Sublingual fentanyl spray | |
MX2010008921A (es) | Derivados de oxazolidinona. | |
PL2371853T3 (pl) | Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna, zastosowanie pochodnej insuliny lub jej farmaceutycznie dopuszczalnej soli oraz sposób leczenia | |
GEP20125624B (en) | Pyridazine derivatives as smo inhibitors | |
MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
IN2012DN01233A (lv) | ||
MX2009010407A (es) | Derivados fluorados de deferiprona. | |
UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
MX2011011109A (es) | Formulaciones orales de bendamustina. | |
MX2013000694A (es) | Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb. | |
MX2012013879A (es) | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. | |
ZA201007391B (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood | |
WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
IL210386A (en) | Indole history, their medicinal preparations, and their use in the preparation of drugs for the treatment or prevention of neurodegenerative diseases | |
NZ602807A (en) | 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one and an mtor inhibitor | |
UA109793C2 (uk) | Арилсульфонаміди для лікування захворювань центральної нервової системи (цнс) |